RLAY · Relay Therapeutics, Inc. Common Stock

RLAY Relay Therapeutics, Inc. Common Stock

Healthcare & Biotech · Healthcare · ← Healthcare & Biotech Index

Gesamt -61%RS-Rating 95vom Hoch -23%Ø $-Vol 55MMax-Runup +881%Max-DD -97%ADR 7.7%Score 101Setups 4Rallyes 8Earnings 22Surf 89%🏄 10/20-Surfer

▲ im Chart anklicken → springt zur Zeile

Grade	Base-Start	Breakout	Tage	Tiefe%	Vorlauf%	Δ Tag%	Gap%	Vol×	Dry-Up%	ADR%	ext10%	Surf%	Setup	Formation	Katalysator
A	2022-08-25	2022-09-08	9	22.2	+113	+23.8	12.9	5.8	-7	9.5	26	89	Episodic Pivot (Gap)	High Tight Flag	SEC 8-K: Reg FD disclosure ↗
B	2024-07-23	2024-09-09	33	37.6	+68	+52.4	29.0	25.8	35	7.4	36	36	Episodic Pivot (Gap)	—	SEC 8-K: Material agreement
B	2025-11-25	2025-12-12	12	13.5	+134	+3.1	10.4	1.4	13	6.9	4	83	Episodic Pivot (Gap)	High Tight Flag	News: Relay Therapeutics Announces Efficacy Subset Analysis of Zovegalisib (RLY-2608) + Fulvestr ↗
B	2026-04-17	2026-06-02	31	32.9	+135	+10.1	16.8	2.7	-37	7.2	13	40	Episodic Pivot (Gap)	—	—:

Breakouts 4Trefferquote 0%Ø gehalten -15.5%Median -10.8%Ø Peak +10%Ø hergegeben −26%

Breakout	G	Entry	gehalten	Peak	hergeg.	Tage	Exit
2022-09-08	A	26.94	-10.8%	+22.7%	−33.5%	3	2022-09-13
2024-09-09	B	9.77	-23.2%	+9.7%	−33.0%	9	2024-09-20
2025-12-12	B	8.36	-6.0%	+8.1%	−14.1%	14	2026-01-05
2026-06-02	B	17.32	-21.9%	+0.9%	−22.8%	3	2026-06-05

Regel: Einstieg am Breakout-Pivot, Trailing-Stop = Tagesschluss unter dem 20-EMA. gehalten = realisierter Gewinn bis zum Stop · Peak = max. Run-Up (MFE) · hergeg. = Peak − gehalten · „offen" = Position läuft noch.

Jahr	Rendite	Spanne	Max-DD	Setups	Schluss
2020	+19%	77%	-25%		41.56
2021	-26%	150%	-58%		30.71
2022	-51%	180%	-62%	1	14.94
2023	-26%	290%	-74%		11.01
2024	-63%	203%	-66%	1	4.12
2025	+105%	408%	-59%	1	8.46
2026	+60%	149%	-28%	1	13.52

▲ 2025-04-04 → 2026-04-21 +740% (261 HT)

Auslöser: News: Relay Therapeutics Announces Efficacy Subset Analysis of Zovegalisib (RLY-2608) + Fulvestr

2025-12-12 +3% [News] Relay Therapeutics Announces Efficacy Subset Analysis of Zovegalisib (

▲ 2022-06-13 → 2022-09-08 +136% (60 HT)

Auslöser: SEC 8-K: Reg FD disclosure

2022-09-08 +24% [SEC 8-K] Reg FD disclosure

▲ 2023-10-25 → 2024-01-08 +101% (50 HT)

Auslöser: Earnings: Earnings-Report (SEC 8-K 2.02)

2023-11-03 +2% [Earnings] Earnings-Report (SEC 8-K 2.02)

▲ 2022-01-28 → 2022-04-04 +72% (45 HT)

Auslöser: — (Momentum/sektorgetrieben)

▲ 2021-01-11 → 2021-01-22 +65% (8 HT)

Auslöser: — (Momentum/sektorgetrieben)

▲ 2020-08-14 → 2020-11-25 +65% (72 HT)

Auslöser: — (Momentum/sektorgetrieben)

▲ 2022-12-28 → 2023-02-02 +61% (24 HT)

Auslöser: News: Relay Therapeutics, Inc. (RLAY) Soars 20.7%: Is Further Upside Left in the Stock?

2023-01-12 +21% [News] Relay Therapeutics, Inc. (RLAY) Soars 20.7%: Is Further Upside Left in

▲ 2024-04-23 → 2024-07-23 +61% (62 HT)

Auslöser: — (Momentum/sektorgetrieben)